Genetic Polymorphisms in SLC23A2 as Predictive Biomarkers of Severe Acute Toxicities after Treatment with a Definitive 5-Fluorouracil/Cisplatin-Based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma

Objective: Definitive chemoradiotherapy (CRT) with 5-fluorouracil (5-FU) and cisplatin (CDDP) is one of the standard therapies for esophageal squamous cell carcinoma (ESCC); however, inter-individual variations in clinical outcomes have yet to be investigated. In the present study, single nucleotide...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Minegaki, Tetsuya, Kuwahara, Akiko, Yamamori, Motohiro, Nakamura, Tsutomu, Okuno, Tatsuya, Miki, Ikuya, Omatsu, Hideaki, Tamura, Takao, Hirai, Midori, Azuma, Takeshi, Sakaeda, Toshiyuki, Nishiguchi, Kohshi
Format: Artigo
Idioma:Inglês
Publicat: Ivyspring International Publisher 2014
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3936025/
https://ncbi.nlm.nih.gov/pubmed/24578608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.7654
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars